Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Kumagai Gumi, The Current Fiscal Year Ordinary Profit Revised Downward to an Unexpected 8% Decrease
1861 Kumagai Gumi Co.,Ltd. 【J-GAAP】
Earnings ReportKumagai Gumi Co.,Ltd. <1861> [TSE Prime] announced its financial results after the market closed on February 13th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) significantly dropped 83.2% from the same period last year to 1.57 billion yen.
In addition, the full-year consolidated ordinary profit has decreased 22.1%, from the previous forecast of 15.4 billion yen to 12 billion yen (compared to 13 billion yen in the previous period). This changes the outlook from an anticipated profit increase to a projection of a 8.0% decrease in profit.
Based on the full-year plan announced by the company after the downward revision, our estimate of the consolidated ordinary profit for the October to March period (2H) has decreased 24.0%, from the previous forecast of 14.1 billion yen to 10.7 billion yen (compared to 9.04 billion yen in the same period of the previous year), leading to a reduction in the profit growth rate from 56.5% to 18.9%.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit significantly dropped to 0.32 billion yen, a 93.9% decrease compared to the same period last year. The operating profit margin drastically worsened from 4.9% in the same period last year to 0.3%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 285,577 | 5,753 | 6,371 | 3,988 | 89.4 | 52.1 | Feb 10, 2023 | J-GAAP |
Apr - Dec, 2023 | 307,754 | 9,253 | 9,350 | 5,919 | 136.7 | 71.7 | Feb 13, 2024 | J-GAAP |
Apr - Dec, 2024 | 330,709 | 1,581 | 1,575 | 583 | 13.6 | 13.1 | Feb 13, 2025 | J-GAAP |
YoY | +7.5% | -82.9% | -83.2% | -90.2% | -90.1% |
Guidance Update
Second Half Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2024 Prev | 242,708 | 13,761 | 14,151 | 9,574 | 223.1 | 130 | Nov 12, 2024 | J-GAAP |
Oct - Mar, 2024 New | 270,508 | 10,561 | 10,751 | 7,174 | 167.1 | 130 | Feb 13, 2025 | J-GAAP |
Revision Rate | +11.5% | -23.3% | -24.0% | -25.1% | -25.1% |
Full Year Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2025 Prev | 462,200 | 15,000 | 15,400 | 10,100 | 235.3 | 130 | May 14, 2024 | J-GAAP |
Mar, 2025 New | 490,000 | 11,800 | 12,000 | 7,700 | 179.4 | 130 | Feb 13, 2025 | J-GAAP |
Revision Rate | +6.0% | -21.3% | -22.1% | -23.8% | -23.8% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 246,936 | 8,881 | 9,044 | 5,885 | 136.1 | 130 | May 14, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 270,508 | 10,561 | 10,751 | 7,174 | 167.1 | 130 | Feb 13, 2025 | J-GAAP |
YoY | +9.5% | +18.9% | +18.9% | +21.9% | +22.8% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 403,502 | 11,483 | 12,236 | 7,973 | 179.6 | 130 | May 12, 2023 | J-GAAP |
Mar, 2024 | 443,193 | 12,649 | 13,040 | 8,316 | 192.4 | 130 | May 14, 2024 | J-GAAP |
Mar, 2025 Guidance | 490,000 | 11,800 | 12,000 | 7,700 | 179.4 | 130 | Feb 13, 2025 | J-GAAP |
YoY | +10.6% | -6.7% | -8.0% | -7.4% | -6.7% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 111,497 | 5,485 | 5,354 | 3,488 | 80.6 | 4.9 | Feb 13, 2024 | J-GAAP |
Jan - Mar, 2024 | 135,439 | 3,396 | 3,690 | 2,397 | 55.5 | 2.5 | May 14, 2024 | J-GAAP |
Apr - Jun, 2024 | 102,676 | 451 | 372 | 109 | 2.5 | 0.4 | Aug 9, 2024 | J-GAAP |
Jul - Sep, 2024 | 116,816 | 788 | 877 | 417 | 9.7 | 0.7 | Nov 12, 2024 | J-GAAP |
Oct - Dec, 2024 | 111,217 | 342 | 326 | 57 | 1.3 | 0.3 | Feb 13, 2025 | J-GAAP |
YoY | -0.3% | -93.8% | -93.9% | -98.4% | -98.3% |
Related Articles
Pan Pacific International, The Current Fiscal Year Ordinary Profit Revised Upward to an Unexpected 1% Increase, Raises Record High Profit
YKT, 89% Increase in Ordinary Profit for The Current Fiscal Year
Jibannet, The Current Fiscal Year Ordinary Profit Revised Upward by 2.2 times
Tokushu Tokai Paper, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 2%
TEAR Corp, Oct-Dec (1Q) Ordinary Profit Increases by 2.4 times
CREATE MEDIC, 39% Increase in Ordinary Profit for The Current Fiscal Year
Disruptors, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 5.6 times, Oct-Dec Ordinary Profit Turns to Profit
TAIKO PHARMA, 71% Decrease in Ordinary Profit for The Current Fiscal Year
Vertex, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 9%
IFIS JAPAN, 14% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen